BigBear.ai (BBAI) stock flat after SEC filing delays share vote again; CargoSeer deal in focus
23 January 2026
1 min read

BigBear.ai (BBAI) stock flat after SEC filing delays share vote again; CargoSeer deal in focus

New York, Jan 23, 2026, 12:53 EST — Regular session

  • BigBear.ai announced the shareholder vote to double its authorized common stock has been delayed to Feb. 18, with voting open through Feb. 17.
  • This week, the company revealed it acquired specific CargoSeer technologies focused on cargo inspection and trade-risk management.

BigBear.ai Holdings shares barely moved Friday after the company delayed a shareholder vote yet again. The vote concerns a proposal to double its authorized common stock to 1 billion shares. Electronic voting remains open through Feb. 17, ahead of the reconvened meeting set for Feb. 18, according to an SEC filing. The stock last dipped about 0.1% to $5.93, having fluctuated between $5.76 and $6.03 during the session, with around 39 million shares changing hands. 1

The vote is crucial since “authorized shares” define the legal limit on how many shares a company can issue. Increasing that limit doesn’t dilute investors on its own, but it opens the door for fresh fundraising, stock-based compensation, or shares used in acquisitions.

It’s concrete for BigBear.ai at the moment. The McLean, Virginia-based firm revealed late Wednesday it picked up specific technologies from CargoSeer, Ltd., a company specializing in cargo scanning and trade risk management software. The purchase price wasn’t disclosed. 2

CargoSeer’s platform focuses on “non-intrusive inspection,” using imaging systems to scan cargo without opening containers. It combines automated image analysis, computer vision, and machine learning with trade and cargo data, the companies said. BigBear.ai CEO Kevin McAleenan noted the acquisition will help “support customs agencies.” Meanwhile, CargoSeer co-founder and CEO David Smason expects the technology to “scale rapidly.” 3

Broader U.S. stocks were creeping up during the session, with the SPDR S&P 500 ETF ticking up roughly 0.1% and the Invesco QQQ Trust gaining around 0.4%.

AI-linked stocks showed a split performance. Palantir Technologies climbed roughly 2.8%, but C3.ai edged down by about 0.9%.

For small, volatile stocks, these share-vote developments can still pack a punch, even if the price barely shifts. Investors see them as clues about how much equity the board plans to hold back—and their reasons for doing so.

The deal has its downsides. Buying CargoSeer brings integration risks and, so far, limited concrete data. The longer the vote on share authorization drags out, the more concerns about dilution could mount. On another front, Pomerantz Law Firm announced Thursday it’s investigating claims on behalf of BigBear.ai investors. 4

Traders are focused on one key date: Feb. 18. That’s when the company’s Proposal 1 vote happens. They’ll also be looking for any follow-up disclosures to clarify exactly what the CargoSeer assets bring to the table — and their price tag.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
D-Wave Quantum stock slides 5% as share-resale filing hangs over QBTS trade
Previous Story

D-Wave Quantum stock slides 5% as share-resale filing hangs over QBTS trade

Micron stock slips as William Blair flags AI “memory bottlenecks”; Fed decision ahead
Next Story

Micron stock slips as William Blair flags AI “memory bottlenecks”; Fed decision ahead

Go toTop